CHOLESTYRAMINE
Fifteen stocks in focus on Thursday, 27 April 2017Axis Bank on Wednesday reported a massive 43 per cent plunge in the March quarter net at Rs 1,225 crore
Zydus Cadila gets USFDA nod for anti-cholesterol drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market the product, Zydus Cadila said in a stat...
- Load More